Company Filing History:
1 out of 441 
1 out of 4,455 
1 out of 4,945 
Years Active: 2012-2016
Title: Inventor Spotlight: Dirk Ponsel
Introduction: Dirk Ponsel is an accomplished inventor located in Germering, Germany. With a strong focus on biomedicine, he holds three patents that showcase his innovative contributions to the field. His work significantly impacts therapeutic methods for various diseases.
Latest Patents: Ponsel’s recent patents include a groundbreaking invention involving platelet-derived growth factor B specific antibodies. This invention provides antibodies that specifically bind to PDGF-B and details a method for obtaining such antibodies along with nucleic acids encoding them. These antibodies lend themselves to compositions and therapeutic methods for the treatment and prevention of PDGF-B mediated diseases, disorders, or conditions. Another notable invention is an isolated antibody targeting the osteoclast-related protein Siglec-15. This antibody is capable of binding Siglec-15, inhibiting osteoclast formation and/or osteoclastic bone resorption. It includes specific sequences that ensure precision in targeting.
Career Highlights: Dirk Ponsel has made significant strides in his career, working with prestigious companies like Daiichi Sankyo Company, Limited and Pfizer Corporation. His expertise in the field of biomedicine has contributed to advancements in therapeutic antibodies and related technologies.
Collaborations: Throughout his career, Ponsel has collaborated with esteemed colleagues such as Sandra Miller and Ichiro Watanabe. These partnerships have further enriched his work, allowing him to leverage diverse insights and expertise within the biotech sector.
Conclusion: Dirk Ponsel’s impressive portfolio of patents and collaborations marks him as a notable figure in the field of biomedicine. His contributions to the development of innovative therapeutic solutions highlight the importance of ongoing research and collaboration in advancing healthcare.